Skip to content

Neurostimulation for Cognitive Rehabilitation in Stroke

Neurostimulation for Cognitive Enhancement After Stroke (NeuroCog)

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02315807
Acronym
NeuroCog
Enrollment
60
Registered
2014-12-12
Start date
2015-12-31
Completion date
2016-07-31
Last updated
2015-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Infarction, Cognitive Impairment, Stroke

Brief summary

Transcranial direct current stimulation has shown promising results in stroke patients. This study is a double blind, sham-controlled clinical trial aiming to compare the long-term effects of stimulation in two different cognitive regions after a stroke. Sixty patients who suffer from chronic strokes will be randomized into 1 of 3 groups: dorsolateral prefrontal cortex, cingulo-opercular network and motor primary cortex (control). Each group will receive transcranial direct current stimulation for 20 minutes for 10 consecutive working days (2 weeks). Patients will be assessed with a Dysexecutive Questionnaire, Semantic Fluency test, categorical verbal fluency and Go-no go tests, Wechsler Adult Intelligence Scale, Rey Auditory-Verbal Learning Test, Letter Comparison and Pattern Comparison Tasks at baseline, after their tenth stimulation session (week 2) and endpoint (week 4). Those who achieve clinical improvement with neurostimulation will be invited to receive treatment for 12 months as part of a follow-up study.

Interventions

DEVICEtranscranial direct current stimulation

Sponsors

Universidade Federal do Rio Grande do Norte
CollaboratorOTHER
Federal University of Paraíba
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Ischaemic chronic stroke * Mild/Moderate Cognitive impairment * Informed consent

Exclusion criteria

* National Institute of Health Stroke Scale (NIHSS) ≥ 16 points * Severe cognitive comorbidities (dementia, depression) * transcranial direct current stimulation criteria: use of modulators of the Central Nervous System drugs; patients with implanted metallic or electronic devices; pacemaker; seizures; pregnancy;any other condition that might limit or interfere in the sensorimotor system

Design outcomes

Primary

MeasureTime frame
Executive Function measured by Dysexecutive Questionnaire (DEX)Change for executive functions at 4 weeks

Secondary

MeasureTime frame
Verbal Fluency (Semantic Fluency Test)[ Time Frame: Baseline, Week 2 and Week 4 ]
Response inhibition (Go-no-go Test)[ Time Frame: Baseline, Week 2 and Week 4 ]
Executive function (Wechsler Intelligence Scale for Adults)[ Time Frame: Baseline, Week 2 and Week 4 ]
Memory (Rey Auditory Verbal Learning)[ Time Frame: Baseline, Week 2 and Week 4 ]
Processing Speed (Letter Comparison and Pattern Comparison Tasks)[ Time Frame: Baseline, Week 2 and Week 4 ]

Countries

Brazil

Contacts

Primary ContactSuellen Andrade
suellenandrade@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026